Getting the wrong diagnosis is not a minor inconvenience — it can mean years of untreated complications and missed screening for relatives who also carry the genetic risk. A new clinical review published in the Cleveland Clinic Journal of Medicine by Sharma, Jansson-Knodell, and Rubio-Tapia sets out to fix a persistent problem: how should clinicians systematically tell celiac disease apart from other conditions that cause similar reactions to gluten or wheat?
That question is harder than it sounds. Celiac disease, non-celiac gluten sensitivity (NCGS), and wheat allergy can all produce overlapping symptoms — bloating, diarrhea, abdominal pain, fatigue — yet they are distinct conditions with very different long-term management, monitoring needs, and implications for the patient’s family.
What This Means for You
The difference between a celiac diagnosis and an NCGS diagnosis is not academic — it determines how aggressively a patient needs to be monitored for life.
Celiac disease carries ongoing obligations that NCGS does not. Celiac patients need regular follow-up for bone density loss (caused by poor absorption of calcium and vitamin D), iron-deficiency anemia, and associated autoimmune conditions including thyroid disease and type 1 diabetes. First-degree relatives — parents, children, siblings — should be screened for celiac because the condition is strongly genetic. None of that applies to NCGS. A patient incorrectly labeled as “gluten sensitive” rather than celiac may never receive those protections.
The distinction shaped everything in our family. My son has celiac disease, not NCGS, and that specific diagnosis determined what foods are safe for him, how strictly we read labels, which restaurants we trust, and which relatives his doctor recommended for testing. A vague “gluten problem” label without a proper workup would have left all of that on the table.
One of the most practically important messages in this kind of clinical guidance is this: do not start a gluten-free diet before completing diagnostic testing. Once gluten is removed from the diet, the antibodies that confirm celiac disease drop — sometimes below detectable levels within weeks. Getting an accurate result after going gluten-free often requires a prolonged and uncomfortable gluten challenge. If you or a family member has symptoms and has not been tested yet, stay on gluten until the workup is complete.
Key Takeaways
- Celiac disease, non-celiac gluten sensitivity, and wheat allergy share symptoms but are different conditions requiring different management.
- A celiac diagnosis triggers long-term complication monitoring and first-degree relative screening — NCGS does not.
- Do not begin a gluten-free diet before diagnostic testing; it makes accurate celiac diagnosis significantly harder.
- A negative HLA-DQ2/DQ8 genetic test essentially rules out celiac disease and can redirect the diagnostic search.
- NCGS is a diagnosis of exclusion — it can only be confirmed after celiac disease and wheat allergy have both been ruled out.
The Science
Want to understand how this actually works? We’ll walk you through the technical details below and define every term. No medical degree required.
The Spectrum of Gluten- and Wheat-Related Disorders
Celiac disease is an autoimmune condition triggered by gluten — the protein found in wheat, barley, and rye. In celiac patients, gluten exposure causes the immune system to attack the lining of the small intestine, damaging the villi (tiny finger-like projections responsible for nutrient absorption). That damage leads to malabsorption of vitamins and minerals, even in patients who appear outwardly healthy.
Non-celiac gluten sensitivity (NCGS), also called non-celiac wheat sensitivity, causes real symptoms — gastrointestinal distress, fatigue, brain fog, joint pain — but without the intestinal damage or the specific antibodies characteristic of celiac disease. The mechanism is not well understood. Gluten alone may not be the driver; FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols — short-chain carbohydrates that ferment in the gut) and other wheat proteins may contribute to symptoms in many patients labeled as NCGS.
Wheat allergy is an IgE-mediated immune reaction — the same mechanism behind peanut or shellfish allergies. It can cause immediate symptoms including hives, swelling, or anaphylaxis. Unlike celiac, it is confirmed through skin prick tests and specific IgE blood panels, and some patients, particularly children, may outgrow it over time.
Two rarer conditions round out the picture: dermatitis herpetiformis (DH), the skin form of celiac disease, presents as an intensely itchy blistering rash and is diagnosed by skin biopsy revealing IgA deposits in the dermis. Gluten ataxia is a neurological condition in which gluten exposure damages the cerebellum — the part of the brain controlling balance — causing coordination problems that can be mistaken for other neurological diseases.
How Clinicians Work Through the Differential
The review lays out a structured diagnostic pathway. The first step is serological testing — blood work — performed while the patient is still consuming gluten. The key markers are:
- Anti-tissue transglutaminase IgA (tTG-IgA): the primary screening antibody for celiac disease
- Total serum IgA: run alongside tTG-IgA to catch selective IgA deficiency, which affects roughly 2–3% of celiac patients and can produce falsely negative tTG-IgA results
- Deamidated gliadin peptide IgG (DGP-IgG): used when IgA deficiency is present or tTG-IgA results are borderline
A positive tTG-IgA strongly suggests celiac disease but is not the final word. Confirmation requires a duodenal biopsy — a tissue sample collected during upper endoscopy — showing characteristic intestinal changes, graded on the Marsh-Oberhuber scale from Marsh 1 (mild lymphocyte infiltration) to Marsh 3 (complete villous atrophy, or flattening of the nutrient-absorbing villi).
HLA typing — testing for the HLA-DQ2 and HLA-DQ8 genetic variants — is a powerful exclusionary tool. Roughly 95% of celiac patients carry HLA-DQ2, and most of the remainder carry HLA-DQ8. A patient who carries neither variant has less than a 1% chance of having celiac disease. That makes a negative HLA result extremely useful: it essentially closes the celiac chapter and directs the evaluation toward other diagnoses, without the need for endoscopy.
Confirming NCGS
NCGS has no established biomarker. Confirming it requires eliminating the alternatives: celiac disease (via serology, biopsy, or HLA testing) and wheat allergy (via IgE testing) must both be ruled out. If a patient’s symptoms improve on a gluten-free diet and return when gluten is reintroduced, NCGS becomes the working diagnosis.
The gold-standard confirmation is a double-blind, placebo-controlled gluten challenge: the patient alternates between gluten-containing and gluten-free periods without knowing which phase they are in. This controls for the nocebo effect — the well-documented phenomenon in which patients feel worse simply because they believe they have consumed gluten — and for the likelihood that FODMAPs rather than gluten itself are driving symptoms.
What This Means for Clinical Practice
The authors’ framework is written for clinicians, but its implications reach into every exam room where a patient reports “I think I have a gluten problem.” Earlier coverage on this site explored how primary care providers approach celiac recognition and diagnosis; this new review sharpens the differential with a step-by-step pathway: serology on gluten first, biopsy if serology is positive, HLA testing to exclude celiac when serology is negative but suspicion remains, and the NCGS label reserved for patients who have genuinely cleared celiac and wheat allergy from consideration.
That systematic approach is what celiac patients and their families deserve. Too many adults still receive vague guidance to try a gluten-free diet and see how they feel — advice that, however well-intentioned, can delay accurate diagnosis, mask true celiac disease, and leave serious long-term complications undetected and unmonitored. Papers like this one push toward a higher standard of care, and that matters to every family navigating this diagnosis.
Related Coverage
References
- Sharma RR, Jansson-Knodell C, Rubio-Tapia A. “How do I distinguish celiac disease from other gluten- or wheat-related disorders in an adult patient?” Cleveland Clinic Journal of Medicine. Published September 1, 2026. PubMed